News

Pluristem earlier received an orphan drug status from the FDA for its PLX cell therapy in the treatment of Buerger’s disease and the new filing marks the company’s

The adjuvanted RiVax was found to be safe and well tolerated in the study, conducted in healthy volunteers, and induced better ricin neutralising antibody levels in humans compared

Irbesartan, a generic version of Aprovel (Irbesartan) by Sanofi Pharma Bristol-Myers Squibb SNC, is indicated to treat essential hypertension and renal disease in patients with hypertension and type

Daratumumab is a human CD38 monoclonal antibody which is currently in Phase I/II studies in relapsed, refractory multiple myeloma and is expected to have potential in other cancer

Under the agreement, Acceleron will initially use DocCompliance in its research and development group to provide users with a secure, structured, and controlled environment in the Cloud. The

The oral multi-kinase inhibitor regorafenib is used for the treatment of metastatic and unresectable gastrointestinal stromal tumors (GIST) in pre treated patients with advance in disease. The application

The partnership will facilitate both the companies to develop new products and allow Life Technologies to distribute Sino Biological’s recombinant proteins, antibodies and Elisa kits. Life Technologies expects

The company will shell out $181m to the participating states accordingly to resolve state consumer protection law claims, according to Janssen. All parties including Janssen have defended the

A 25,000ft² increase in production space has enabled technological advances in supplement manufacturing, which includes semi-automatic encapsulation machinery, high-speed machinery and cutting-edge technology. Private Label Nutraceuticals could also